S Mukherjee

Summary

Affiliation: University of Nebraska Medical Center
Country: USA

Publications

  1. pmc A comprehensive review of immunosuppression used for liver transplantation
    Sandeep Mukherjee
    Section of Gastroenterology and Hepatology, University of Nebraska Medical Center, Omaha, NE 68198 3285, USA
    J Transplant 2009:701464. 2009
  2. ncbi request reprint Natural history, risk factors and management of hepatitis C after liver transplantation
    Sandeep Mukherjee
    Nebraska Medical Center, Division of Gastroenterology and Hepatology, Omaha, Nebraska 68198 3285, USA
    Inflamm Allergy Drug Targets 11:124-30. 2012
  3. ncbi request reprint Pegylated interferon alfa-2a and ribavirin for recurrent hepatitis C after liver transplantation
    S Mukherjee
    Section of Gastroenterology and Hepatology, University of Nebraska Medical Center, Omaha, Nebraska 68198 3285, USA
    Transplant Proc 37:4403-5. 2005
  4. ncbi request reprint Comparison of indocyanine green clearance with Child's-Pugh score and hepatic histology: a multivariate analysis
    Sandeep Mukherjee
    Liver Gallbladder Pancreas Center, Section of Gastroenterology and Hepatology, Department of Medicine, State University of New York Upstate Medical University, Syracuse, New York, USA
    Hepatogastroenterology 53:120-3. 2006
  5. ncbi request reprint Impact of pegylated interferon alpha-2B and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C: an open-label series
    Sandeep Mukherjee
    Medicine Section of Gastroenterology, University of Nebraska Medical Center, Omaha, NE 68198 3285, USA
    Liver Int 26:529-35. 2006
  6. ncbi request reprint Fatal liver disease despite sustained eradication of recurrent hepatitis C virus requiring liver retransplantation
    Sandeep Mukherjee
    Section of Gastroenterology and Hepatology, Nebraska Medical Center, Omaha, 68198, USA
    Transplantation 82:286-8. 2006
  7. ncbi request reprint Impact of pegylated interferon alfa-2a and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C: an open-label series
    Sandeep Mukherjee
    Section of Gastroenterology and Hepatology, Nebraska Medical Center, Omaha, 68198 3283, USA
    Hepatogastroenterology 53:561-5. 2006
  8. doi request reprint Controversies in liver transplantation for hepatitis C
    Sandeep Mukherjee
    Section of Gastroenterology and Hepatology, Nebraska Medical Center, Omaha, Nebraska 68198 3285, USA
    Gastroenterology 134:1777-88. 2008
  9. ncbi request reprint Liver transplant for viral hepatitis and fulminant hepatic failure
    S Mukherjee
    Section of Gastroenterology and Hepatology University of Nebraska Medical Center, USA
    Minerva Gastroenterol Dietol 55:83-100. 2009
  10. ncbi request reprint Immunosuppression in liver transplantation
    Sandeep Mukherjee
    Section of Gastroenterology and Hepatology, 983285 Nebraska Medical Center, Omaha, NE 68198 3285, USA
    Curr Drug Targets 10:557-74. 2009

Collaborators

  • Jean F Botha
  • T M McCashland
  • A Elhendy
  • Wendy J Grant
  • Ira J Fox
  • Debra L Sudan
  • I Bhat
  • Jeane M Tsutsui
  • Adama R Trimnell
  • A Benner
  • E Lyden
  • A Sanjeevi
  • Philip Awadalla
  • Susan M Kraemer
  • Eric Flamoe
  • Joel H Janes
  • Xin Zhuan Su
  • Edward O'Leary
  • Feng Xie
  • Elizabeth R Lyden
  • Joseph D Smith
  • Anna C McGrain
  • David J Phippard
  • Thomas R Porter
  • J Rogge
  • L Weaver
  • R Ashwathnarayan
  • R Weseman
  • B Sunderman
  • G M Comer
  • D J Clain
  • J V Scholes
  • L G Holness

Detail Information

Publications31

  1. pmc A comprehensive review of immunosuppression used for liver transplantation
    Sandeep Mukherjee
    Section of Gastroenterology and Hepatology, University of Nebraska Medical Center, Omaha, NE 68198 3285, USA
    J Transplant 2009:701464. 2009
    ..This review will discuss commonly used immunosuppressants prescribed in liver transplantation, emerging therapties and where appropriate, the impact of these medications on the recurrence of hepatitis C after liver transplantation...
  2. ncbi request reprint Natural history, risk factors and management of hepatitis C after liver transplantation
    Sandeep Mukherjee
    Nebraska Medical Center, Division of Gastroenterology and Hepatology, Omaha, Nebraska 68198 3285, USA
    Inflamm Allergy Drug Targets 11:124-30. 2012
    ....
  3. ncbi request reprint Pegylated interferon alfa-2a and ribavirin for recurrent hepatitis C after liver transplantation
    S Mukherjee
    Section of Gastroenterology and Hepatology, University of Nebraska Medical Center, Omaha, Nebraska 68198 3285, USA
    Transplant Proc 37:4403-5. 2005
    ..This article reports a transplantation program's experience with antiviral therapy treatment for liver transplant recipients with recurrent HCV...
  4. ncbi request reprint Comparison of indocyanine green clearance with Child's-Pugh score and hepatic histology: a multivariate analysis
    Sandeep Mukherjee
    Liver Gallbladder Pancreas Center, Section of Gastroenterology and Hepatology, Department of Medicine, State University of New York Upstate Medical University, Syracuse, New York, USA
    Hepatogastroenterology 53:120-3. 2006
    ..The aims of this study were to compare liver histology and Child's-Pugh score with percentage disappearance rate and determine which variables correlated with PDR...
  5. ncbi request reprint Impact of pegylated interferon alpha-2B and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C: an open-label series
    Sandeep Mukherjee
    Medicine Section of Gastroenterology, University of Nebraska Medical Center, Omaha, NE 68198 3285, USA
    Liver Int 26:529-35. 2006
    ..We describe our experience with pegylated interferon and ribavirin and the impact of this therapy on hepatic fibrosis...
  6. ncbi request reprint Fatal liver disease despite sustained eradication of recurrent hepatitis C virus requiring liver retransplantation
    Sandeep Mukherjee
    Section of Gastroenterology and Hepatology, Nebraska Medical Center, Omaha, 68198, USA
    Transplantation 82:286-8. 2006
    ....
  7. ncbi request reprint Impact of pegylated interferon alfa-2a and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C: an open-label series
    Sandeep Mukherjee
    Section of Gastroenterology and Hepatology, Nebraska Medical Center, Omaha, 68198 3283, USA
    Hepatogastroenterology 53:561-5. 2006
    ..Patients with recurrent hepatitis C are often treated with interferon-based therapy in an attempt to prevent cirrhosis requiring retransplantation. We describe our experience with 32 patients with recurrent HCV...
  8. doi request reprint Controversies in liver transplantation for hepatitis C
    Sandeep Mukherjee
    Section of Gastroenterology and Hepatology, Nebraska Medical Center, Omaha, Nebraska 68198 3285, USA
    Gastroenterology 134:1777-88. 2008
    ..This review is not an inclusive review of the literature but summarizes what we believe are the more controversial topics of this disease...
  9. ncbi request reprint Liver transplant for viral hepatitis and fulminant hepatic failure
    S Mukherjee
    Section of Gastroenterology and Hepatology University of Nebraska Medical Center, USA
    Minerva Gastroenterol Dietol 55:83-100. 2009
    ..This review article will discuss liver transplantation for HBV and HCV and will conclude with reviewing the etiology, epidemiology and management of FHF...
  10. ncbi request reprint Immunosuppression in liver transplantation
    Sandeep Mukherjee
    Section of Gastroenterology and Hepatology, 983285 Nebraska Medical Center, Omaha, NE 68198 3285, USA
    Curr Drug Targets 10:557-74. 2009
    ..This article will review currently used immunosuppressants in liver transplantation, novel therapies in development and the impact of these medications of the recurrence of hepatitis C after liver transplantation...
  11. ncbi request reprint Interferon alpha 2b and ribavirin for the treatment of recurrent hepatitis C after liver transplantation: cohort study of 38 patients
    Sandeep Mukherjee
    Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA
    J Gastroenterol Hepatol 20:198-203. 2005
    ..Patients are often treated with interferon and ribavirin in an attempt to eradicate the virus. We describe our experience with 38 patients with recurrent HCV from a single liver transplant program...
  12. ncbi request reprint Pilot study of pegylated interferon alfa-2b and ribavirin for recurrent hepatitis C after liver transplantation
    S Mukherjee
    Section of Gastroenterology and Hepatology, University of Nebraska Medical Center, 983285 Nebraska Medical Center, Omaha, NE 68198, USA
    Transplant Proc 35:3042-4. 2003
    ..Given the promising results reported with pegylated interferon and ribavirin for hepatitis C, we were interested in evaluating the effectiveness of this treatment in liver transplant recipients with recurrent hepatitis C (HCV)...
  13. ncbi request reprint Pegylated interferon for recurrent hepatitis C in liver transplant recipients with renal failure: a prospective cohort study
    S Mukherjee
    Department of Medicine, University of Nebraska Medical Center, Omaha, Nebraska 68198, USA
    Transplant Proc 35:1478-9. 2003
    ..In this setting of renal failure, pegylated-interferon monotherapy may be useful for recurrent HCV in liver transplant patients...
  14. ncbi request reprint Hepatitis C recurrence after liver transplantation
    I Bhat
    Section of Gastroenterology and Hepatology, Nebraska Medical Center, Omaha, NE 68198 3285, USA
    Panminerva Med 51:235-47. 2009
    ..Side effects are common and can lead to dose reduction or discontinuation of treatment. For those patients who develop develop decompensated cirrhosis from recurrent hepatitis C, retransplantation may be considered...
  15. ncbi request reprint De novo cryptogenic hepatitis after sustained eradication of hepatitis C following liver transplantation
    S Mukherjee
    Section of Gastroenterology and Hepatology University of Nebraska Medical Center, Omaha, Nebraska, USA
    Transplant Proc 36:1494-7. 2004
    ..We have not found any similar reports in the literature but anticipate more cases to be reported given the universal use of antiviral therapy for recurrent HCV...
  16. ncbi request reprint Outcomes of liver transplantation for hepatitis B: a single-center study of 35 patients
    A Benner
    Section of Gastroenterology and Hepatology, University of Nebraska Medical Center, Omaha, Nebraska 68198 3285, USA
    Transplant Proc 36:2741-3. 2004
    ..The aims of this study were to evaluate outcomes of LT for HBV and describe the prevalence of drug resistance...
  17. ncbi request reprint Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation
    Jean F Botha
    Department of Surgery, University of Nebraska Medical Center, Omaha, NE 68198 3285, USA
    Liver Int 27:758-63. 2007
    ..This study examines the impact of donor liver macrovesicular steatosis on recurrence of hepatitis C virus (HCV) disease after liver transplantation...
  18. ncbi request reprint Diarrhea associated with lansoprazole
    Sandeep Mukherjee
    Section of Gastroenterology, State University of New York Health Science at Syracuse and Veterans Affairs Medical Center, Syracuse, New York, USA
    J Gastroenterol Hepatol 18:602-3. 2003
    ..The case is reviewed and possible mechanisms of diarrhea secondary to proton pump inhibitors are discussed...
  19. ncbi request reprint Liver biopsies in the acquired immune deficiency syndrome: influence of endemic disease and drug abuse
    G M Comer
    Department of Medicine, Harlem Hospital Center, New York, NY
    Am J Gastroenterol 84:1525-31. 1989
    ..Liver biopsy can provide important diagnostic information in AIDS patients. The pathological findings in this series reflect the high risk of exposure to tuberculosis and hepatitis in the intravenous drug abusers in Harlem...
  20. ncbi request reprint Outcomes of liver transplantation for cryptogenic cirrhosis: a single-center study of 71 patients
    A Sanjeevi
    Section of Gastroenterology and Hepatology, University of Nebraska Medical Center, Omaha, NE 68198 3285, USA
    Transplant Proc 35:2977-80. 2003
    ..Our aim was to identify risk factors associated with nonalcoholic steatohepatitis (NASH) in patients with CC and to evaluate outcomes following OLT...
  21. ncbi request reprint Noninvasive tests for liver fibrosis
    Sandeep Mukherjee
    Department of Medicine, Section of Gastroenterology Hepatology, University of Nebraska Medical Center and Veterans Affairs Medical Center, Omaha, Nebraska, USA
    Semin Liver Dis 26:337-47. 2006
    ..With time, it is anticipated a combination of serological and radiological tests together with genetic and proteomic investigations will provide accurate assessment of fibrosis in a cost-effective and timely manner...
  22. ncbi request reprint Value of dobutamine stress myocardial contrast perfusion echocardiography in patients with advanced liver disease
    Jeane M Tsutsui
    Department of Internal Medicine, Section of Cardiology, University of Nebraska Medical Center, Omaha, NE 68198 1165, USA
    Liver Transpl 12:592-9. 2006
    ..003). In conclusion, MPI obtained by RTMCE appears to be a useful tool in predicting mortality in patients with ALD. Further studies are required to verify its independent value...
  23. ncbi request reprint Liver transplantation and hepatitis C virus
    Sandeep Mukherjee
    Transplantation 80:1817. 2005
  24. ncbi request reprint Interferon alpha-2b and ribavirin for patients with chronic hepatitis C and normal ALT
    Sandeep Mukherjee
    Am J Gastroenterol 100:727; author reply 727. 2005
  25. ncbi request reprint Severe cholestasis in a patient with acute hepatitis C treated with interferon alpha-2b
    Sandeep Mukherjee
    Am J Gastroenterol 97:2152-3. 2002
  26. ncbi request reprint Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2b and ribavirin for recurrent hepatitis C
    Sandeep Mukherjee
    J Gastroenterol Hepatol 19:723-4. 2004
  27. ncbi request reprint Successful Hepatitis C Eradication With Preservation of Renal Function in a Liver/kidney Transplant Recipient Using Pegylated Interferon and Ribavirin
    Sandeep Mukherjee
    Transplantation 84:1374-5. 2007
  28. ncbi request reprint The TMC study
    Sandeep Mukherjee
    Lancet 361:345-6; author reply 347. 2003
  29. ncbi request reprint Global genetic diversity and evolution of var genes associated with placental and severe childhood malaria
    Adama R Trimnell
    Seattle Biomedical Research Institute, Seattle, WA, USA
    Mol Biochem Parasitol 148:169-80. 2006
    ..These studies aid our understanding of the evolutionary mechanisms that shape var diversity and will be important to the development of vaccines against pregnancy associated malaria and severe malaria...
  30. ncbi request reprint Beta-blockers to prevent esophageal varices--an unfulfilled promise
    Sandeep Mukherjee
    N Engl J Med 353:2288-90. 2005
  31. ncbi request reprint Adefovir dipivoxil for hepatitis B e antigen-positive chronic hepatitis B
    Sandeep Mukherjee
    N Engl J Med 348:2468; author reply 2468. 2003